Back

Crinetics Pharmaceuticals Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Buy

CRNX
Crinetics Pharmaceuticals

Last Price:

59.10

Seasonality Move:

10.45%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Crinetics Pharmaceuticals Stock Forecast

Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 28.9% based on the past 6 years of stock performance.
Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Crinetics Pharmaceuticals Stock Undervalued?
The current Crinetics Pharmaceuticals [CRNX] share price is $57.81. The Score for CRNX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
CRNX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Crinetics Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 28.9% based on the past 6 years of stock performance.

Crinetics Pharmaceuticals Stock Rating

Buy

Crinetics Pharmaceuticals (CRNX) is a Buy

Is Crinetics Pharmaceuticals overpriced?

Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Crinetics Pharmaceuticals Stock Price History

Is CRNX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

crinetics.com

52-Week Data

52-Week High:

60.04

52-Week Low:

25.75

Prediction Charts

Market Cap:

4.63B

Price in USD:

57.81

Volume:

326.42K

Beta:

0.68

Technical Analysis

SMA50:

53.83

SMA100:

51.82

SMA200:

47.57

52-Wk Change:

88.31%

Stock Predictions

Is Crinetics Pharmaceuticals stock public?
Yes, Crinetics Pharmaceuticals is a publicly traded company.
What is the Crinetics Pharmaceuticals stock quote today?
The Crinetics Pharmaceuticals stock price is 57.81 USD today.
How to buy Crinetics Pharmaceuticals stock online?
You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-16	58.28	58.86	59.39	57.10
Oct-18	58.91	59.09	59.80	58.40
Oct-21	58.61	58.70	58.88	57.47
Oct-22	58.49	59.61	60.04	58.26
Oct-23	59.53	58.40	60.00	57.54
Oct-24	58.50	58.74	59.39	58.30
Oct-25	59.22	57.96	59.32	57.86
Oct-28	58.64	57.15	59.67	56.82
Oct-29	56.84	56.26	57.24	56.12
Oct-30	55.91	55.76	56.96	55.43
Oct-31	55.36	55.98	56.54	54.32
Nov-1	56.50	56.69	57.81	56.19
Nov-4	56.17	56.82	58.00	55.21
Nov-5	56.49	57.81	57.88	55.28

Crinetics Pharmaceuticals Earnings

Crinetics Pharmaceuticals Earnings Report: Per Share Crinetics Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Crinetics Pharmaceuticals Forecast Revenue Growth

Crinetics Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.

* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.